Hallmark oncogenic signaling pathways in MM include JAK-STAT3, PI3K/AKT/mTOR, and NF-κB [105,106], in which STAT3 is activated by the IL-6–JAK–STAT3 axis [107,108]. The gene discussed is STAT3; the disease is Miyoshi myopathy.